Neuroblastoma
📧 Sign up to get email alerts when something new happens for Neuroblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma [NA]
This document provides an update on a completed clinical trial evaluating electroacupuncture to treat delayed nausea and vomiting in childre…
-
CLINICAL_TRIALS trial_result · 2013-05-17Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma [Phase 3]
This report updates the completion status of a Phase 3 trial evaluating combination chemotherapy and peripheral stem cell transplantation in…
-
CLINICAL_TRIALS trial_result · 2013-04-26Clinical Trial Update: Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect [Phase 1, Phase 2]
Phase I/II clinical trial updating escalating-dose melphalan with autologous stem cell support and amifostine cytoprotection across multiple…
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma [Phase 1]
Phase 1 study evaluating interleukin-12 and interleukin-2 in patients with refractory or recurrent neuroblastoma; the trial status is termin…
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: A Study of MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients [Phase 2]
A Phase 2 trial comparing MAb-3F8 plus GM-CSF to 13-cis-retinoic acid plus GM-CSF in patients with primary refractory neuroblastoma was term…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Multiple Therapies in Treating Patients With Advanced Neuroblastoma [Phase 2]
Clinical trial update reporting Phase 2 results for multiple therapies in patients with advanced neuroblastoma, sponsored by Memorial Sloan …
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Ethanol-Lock Treatment in Preventing Central Venous Catheter Infections in Patients With High-Risk Neuroblastoma [Phase 1]
This update reports the completion of a Phase 1 trial evaluating ethanol-lock therapy to prevent central venous catheter infections in patie…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Fenretinide in Treating Children With Solid Tumors [Phase 1]
This Clinical Trial Update summarizes a Phase 1 trial of fenretinide in pediatric solid tumors, including neuroblastoma, focusing on safety …
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial of a rebeccamycin analogue in pediatric patients with solid tumors or Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Docetaxel in Treating Children With Recurrent Solid Tumors [Phase 2]
Phase 2 trial evaluating docetaxel in children with recurrent solid tumors has completed; results are summarized in the update.
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma [Phase 1]
Phase 1 clinical trial evaluating the combination of beta-glucan with a monoclonal antibody for metastatic neuroblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer [Phase 1]
A completed Phase 1 trial assessed combining the monoclonal antibody A1G4 with Bacillus Calmette-Guérin (BCG) in patients with neuroblastoma…
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment [Phase 2]
This update reports on a Phase 2 clinical trial investigating a biological therapy for neuroblastoma in patients whose disease did not respo…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma [Phase 1]
Phase 1 trial evaluating a monoclonal antibody therapy in combination with sargramostim and interleukin-2 in children with neuroblastoma has…
-
CLINICAL_TRIALS trial_result · 2012-11-22Clinical Trial Update: Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma [Phase 2]
Phase 2 trial investigating haploidentical natural killer cells in patients with relapsed or refractory neuroblastoma has been terminated; r…
-
CLINICAL_TRIALS trial_result · 2012-11-06Clinical Trial Update: Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma [Phase 2]
Phase 2 clinical trial update evaluating protracted etoposide during induction therapy for high-risk neuroblastoma has completed and posted …
-
CLINICAL_TRIALS trial_result · 2012-10-29Clinical Trial Update: Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory Neuroblastoma [Phase 1]
A Phase 1 clinical trial tested safety and preliminary efficacy of gene-modified neuroblastoma cells in relapsed/refractory neuroblastoma. T…
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy [Phase 1]
A Phase 1 trial evaluating a neuroblastoma vaccine for high-risk neuroblastoma after chemotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: Exploring the Possibility to Use Glycosyltransferase as a Prognosis Marker of Neuroblastoma
A completed clinical trial exploring glycosyltransferase as a potential prognostic biomarker for Neuroblastoma.
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: 131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma [Phase 1, Phase 2]
Clinical trial evaluating 131I-MIBG with myeloablative chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma (Ph…
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors [Phase 1]
Phase 1 trial evaluating ZD1839 (gefitinib) with oral irinotecan in young patients with refractory solid tumors, including glioblastoma, rha…
-
CLINICAL_TRIALS trial_result · 2012-04-02Clinical Trial Update: Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer [Phase 1]
Phase 1 trial assessing continuous hyperthermic peritoneal perfusion with cisplatin in children with peritoneal cancers. The study status is…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: ABT-751 in Treating Young Patients With Refractory Solid Tumors [Phase 1]
A Phase 1 clinical trial of ABT-751 in children with refractory solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors [Phase 1]
Phase 1 trial evaluating talabostat in combination with temozolomide or carboplatin in pediatric patients with relapsed or refractory brain …
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy [Phase 1]
Phase 1 pediatric trial update reports initial safety and dosing information for ixabepilone in children with relapsed or refractory solid t…